ArticleFrontiers in nutrition2026
The gut-brain axis as a therapeutic target in alcohol use disorder: dietary fiber, intestinal barrier integrity, and neuroinflammatory mechanisms underlying depression.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol use disorder is frequently accompanied by major depressive disorder, yet the biological mechanisms linking both conditions remain incompletely understood. Increasing evidence suggests that chronic alcohol consumption disrupts the gut-brain axis by damaging intestinal tight junctions and inducing gut dysbiosis characterized by depletion of short-chain fatty acid-producing bacteria. The resulting impairment of intestinal barrier integrity may facilitate the translocation of bacterial lipopolysaccharide, promoting peripheral and central neuroinflammation through Toll-like receptor 4-dependent pathways. These neuroinflammatory alterations may persist during abstinence and contribute to glutamatergic, dopaminergic, and serotonergic dysregulation associated with depressive symptoms and relapse vulnerability. This Perspective proposes that intestinal barrier dysfunction represents an actionable upstream mechanism linking alcohol-induced gut dysbiosis with neuroinflammation, depression, and relapse vulnerability, and highlights dietary fiber supplementation as a physiologically grounded, accessible nutritional strategy to enhance endogenous butyrate production, improve intestinal barrier integrity, and attenuate neuroinflammatory signaling. Available preclinical and clinical evidence is critically evaluated, and key priorities for future mechanistic and clinical studies are outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.